GoodRx's Wild Ride: Job Market Jitters and AI Hopes
Update: 2025-09-05
Description
GoodRx stock takes a hit amid Wall Street jitters over jobs data, but is it a buying opportunity? Discover why this volatile stock dipped, despite a recent surge from its Novo Nordisk partnership for Wegovy and Ozempic discounts. We'll dive into GoodRx's wild year, its long-term struggles since its IPO, and explore where investors are looking next for tech's gorillas in the age of AI.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
